CU23533A3 - INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM - Google Patents

INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM

Info

Publication number
CU23533A3
CU23533A3 CU20070041A CU20070041A CU23533A3 CU 23533 A3 CU23533 A3 CU 23533A3 CU 20070041 A CU20070041 A CU 20070041A CU 20070041 A CU20070041 A CU 20070041A CU 23533 A3 CU23533 A3 CU 23533A3
Authority
CU
Cuba
Prior art keywords
hepatitis
virus
inhibitors
rna
treatments
Prior art date
Application number
CU20070041A
Other languages
Spanish (es)
Inventor
John Howard Tatlock
Angelica Linton
Tanya Michelle Jewell
Javier Gonzalez
Hui Li
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CU20070041A priority Critical patent/CU23533A3/en
Publication of CU23533A3 publication Critical patent/CU23533A3/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona compuestos de fórmula (4) y sus sales farmacéuticamente aceptables y solvatos, que son útiles como inhibidores de la enzima polimerasa del virus de la Hepatitis C (HCV) y también son útiles para el tratamiento de infecciones por HCV en mamíferos infectados por HCV. La presente invención también proporciona composiciones farmacéuticas que comprenden compuestos de fórmula (4), sus sales farmacéuticamente aceptables y solvatos. Además, la presente invención proporciona compuestos intermedios y métodos útiles en la preparación de compuestos de fórmula (4).The present invention provides compounds of formula (4) and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in infected mammals. by HCV. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. In addition, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).

CU20070041A 2007-02-08 2007-02-08 INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM CU23533A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20070041A CU23533A3 (en) 2007-02-08 2007-02-08 INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20070041A CU23533A3 (en) 2007-02-08 2007-02-08 INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM

Publications (1)

Publication Number Publication Date
CU23533A3 true CU23533A3 (en) 2010-06-17

Family

ID=42633313

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20070041A CU23533A3 (en) 2007-02-08 2007-02-08 INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM

Country Status (1)

Country Link
CU (1) CU23533A3 (en)

Similar Documents

Publication Publication Date Title
NI200700043A (en) INHIBITORS OF RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM.
UY28192A1 (en) INHIBITORS OF RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM.
NI201300107A (en) DERIVATIVES OF NUCLEOSIDES 2 '- SUBSTITUTE AND METHODS OF USE OF THE SAME FOR THE TREATMENT OF VIRAL DISEASES.
MX2013006475A (en) MACROCICLIC INHIBITORS OF VIRUS FLAVIVIRIDAE.
ECSP12011684A (en) FLAVIVIRIDAE VIRUS INHIBITORS.
ECSP12012282A (en) NUCLEOSIDE PHOSPHORAMIDATES
CO6561783A2 (en) FLAVIVIRIDAE VIRUS INHIBITORS
ECSP12012104A (en) VIRUS FLAVIVIRIDAE INHIBITORS
ECSP12012147A (en) FUSIONED TRICHYCLIC SILILO COMPOUNDS AND METHODS OF USE OF THE SAME FOR THE TREATMENT OF VIRAL DISEASES
EA201170915A1 (en) PHOSPHORAMIDATE DERIVATIVES OF GUANOSINE NUCLEOSIDE FOR THE TREATMENT OF VIRAL INFECTIONS
CO6561788A2 (en) HEPATITIS C VIRUS INHIBITORS
CO6571891A2 (en) Hepatitis C virus inhibitors
CL2012002782A1 (en) Compounds derived from pyrazol-4-yl-heterocyclyl-carboxamide, inhibitors of disorders mediated by kinases pim-1, pim-2 and pim-3; pharmaceutical composition; method of treatment; and its use for the treatment of cancer, immune disorders, cardiovascular diseases and viral infections, among others.
CO6382185A2 (en) ANTIVIRAL NUCLEOSID COMPOUNDS
CO6290682A2 (en) INHIBITING FUSIONED TRICICLIC COMPOUNDS OF HEPATITIS VIRUS C.
EA200901241A1 (en) CONNECTIONS FOR THE TREATMENT OF HEPATITIS C
UY31860A (en) PIRIDINES OF TIAZOLO AS INHIBITORS OF THE GIRASA DNA
UY31685A (en) ANTIVIRAL COMPOUNDS, COMPOSITIONS AND METHODS TO USE THEM
UY34066A (en) HEPATITIS C VIRUS INHIBITORS
CY1118729T1 (en) DERIVATIVES 9-methyl substituted EXADEKAFDROKYKLOPROPA (E) pyrrolo (1,2-a) (1,4) DIAZAKYKLOPENTADEKINYL carbamate AS nonstructural 3 (NS3) PROTEASE INHIBITORS FOR THE TREATMENT OF INFECTIONS ID HEPATITIS C
BR112013002729A2 (en) hepatitis c virus inhibitors
BR112014013972A8 (en) hcv inhibitors nssa
BR112013000245A2 (en) heterocyclic antiviral compounds
DOP2005000165A (en) INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM
DOP2004000828A (en) INHIBITORS OF RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENT USED

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)